Covered recipient · General Payments record
NEHA BHASIN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2020–2022
$16,456.74
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $10,625.00 | 1 |
| Travel and Lodging | $5,616.35 | 3 |
| Food and Beverage | $189.56 | 5 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $10,625.00 | 1 |
| Octapharma USA, Inc. | $5,692.58 | 7 |
| GENZYME CORPORATION | $113.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $113.33 | 12/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 965549275 | CMS |
| Novartis Pharmaceuticals Corporation | $10,625.00 | 12/12/2022 | Consulting Fee | Undisputed | 01/23/2026 | 893531143 | CMS |
| Octapharma USA, Inc. | $5,565.67 | 09/22/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 937549747 | CMS |
| Octapharma USA, Inc. | $24.47 | 09/22/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 937549753 | CMS |
| Octapharma USA, Inc. | $21.24 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937549757 | CMS |
| Octapharma USA, Inc. | $21.24 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937549761 | CMS |
| Octapharma USA, Inc. | $26.21 | 09/22/2022 | Travel and Lodging | Undisputed | 01/23/2026 | 937549765 | CMS |
| Octapharma USA, Inc. | $23.82 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937549769 | CMS |
| Octapharma USA, Inc. | $9.93 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937549773 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022
- Source files
- Dataset page · Bulk file · PY2020 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.